263 top medical experts on Hermanski-Pudlak Syndrome across 27 countries and 25 U.S. states, including 123 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Hermanski-Pudlak Syndrome: Syndrome characterized by the triad of oculocutaneous albinism (albinism, oculocutaneous); platelet storage pool deficiency; and lysosomal accumulation of ceroid lipofuscin.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Inherited Blood Coagulation Disorders (1,267), Oculocutaneous Albinism (1,257), Platelet Storage Pool Deficiency (183).
  4. Clinical Trials ClinicalTrials.gov : at least 8 including 3 Completed, 2 Recruiting


  

        

                    


    Computing Expert Listing ...

);